Septerna Earnings
NASDAQ: SEPNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
38.37+1.47 (+3.98%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Septerna earnings summary
In its most recent report on Aug 10, 2026 (Q2 2026), SEPN posted EPS of $-0.29. Revenue for the quarter was $26.7 million. Across the last 8 reports, SEPN shares moved an average of 7.9% (in either direction) in the first trading session after results, rising 4 times and falling 4 times.
Summary generated from market data by MetaCap's automated system. Methodology
SEPN earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 10, 2026 | — | $-0.29 | — | -10.1% |
| May 11, 2026 | — | $-0.19 | — | +5.2% |
| Mar 9, 2026 | — | $-0.23 | — | -3.8% |
| Nov 10, 2025 | — | $0.18 | — | +9.9% |
| Aug 11, 2025 | — | $-0.56 | — | +2.3% |
| May 15, 2025 | — | $-0.49 | — | -6.6% |
| Mar 27, 2025 | — | $14.52 | — | -10.2% |
| Nov 20, 2024 | — | $-8.40 | — | +15.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.